SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-143052
Filing Date
2021-11-23
Accepted
2021-11-23 16:30:26
Documents
13
Period of Report
2021-11-17
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133663d1_8k.htm   iXBRL 8-K 29349
2 EXHIBIT 16.1 tm2133663d1_ex16-1.htm EX-16.1 2890
  Complete submission text file 0001104659-21-143052.txt   207401

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20211117.xsd EX-101.SCH 3055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20211117_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20211117_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2133663d1_8k_htm.xml XML 3651
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 211438907
SIC: 2834 Pharmaceutical Preparations